From Research to Legalization: How Cannabis Exploits the Endocannabinoid System
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: 31 December 2024 | Viewed by 419
Special Issue Editors
Interests: fetal development; neuropeptide signaling; psychoactive drugs; maternal drug exposure
Special Issue Information
Dear Colleague,
This Special Issue titled “From research to legalization: how cannabis exploits the endocannabinoid system” aims to bring together novel developments on the involvement of (endo)-cannabinoid signaling in fundamental brain functions in the context of the ongoing European debate on cannabis legalization. Given the increasing availability of cannabis for medicinal and recreational purposes, the selective cultivation of high-THC strains, as well as novel solutions to more efficiently consume cannabis, it is of crucial importance to put anecdotal evidence on how (endo)-cannabinoid signaling controls the nervous system straight through elegant fundamental research. Therefore, we embark on this special issue to gather the most recent original experimental research, comprehensive reviews, as well as opinion pieces from developmental biology to aging, to cannabinoid pharmacology, to health and disease, as well as translational (“human specific”) segments of science. We thus approach you, leaders in this research arena, for your contribution to help illustrate mechanisms, address societal discussion points, and provide perspectives for law and decision-makers by being involved in this special issue. We are looking forward to your feedback and contributions
Dr. Erik Keimpema
Prof. Dr. Tibor Harkany
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- endocannabinoids
- cannabis
- legalization
- THC
- disease
- development
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
